Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 175,000 shares at $16.52 ($2.9M) on 2024-09-10, disclosed to the SEC on 2024-09-12.
Scheduled sale ($2.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |